The action, filed on Monday in the United States District Court for the District of Delaware, targets Annora Pharma Private Limited and associated entities, which have filed an Abbreviated New ...
The action, filed on Monday in the United States District Court for the District of Delaware, targets Annora Pharma Private Limited and associated entities, which have filed an Abbreviated New Drug ...
OKYO Pharma (OKYO) announces the filing of its application for Fast Track designation, FTD, with the U.S. Food and Drug Administration, FDA, for urcosimod for the treatment of neuropathic corneal ...
In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Inozyme Pharma (INZY – Research Report). The company’s shares opened today at $1.14. Effectively assess a stock ...
Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles Annora Spence is a British Postwar & Contemporary artist who was born in 1963.
Perform material- and labor-effective extrusion with Thermo Scientificâ„¢ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. The White House withdrew President Donald Trump's nomination of former ...
This investment will help build a 103,000-square-foot R&D center and a GMP manufacturing facility in Edmonton, Alberta. The biomanufacturing facility will develop and produce the Entos Fusogenix ...
The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...
Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results